CPTCF (Cytophage Technologies) Net Debt Paydown Yield % : 62.81% (As of Jul. 05, 2026)


CPTCF Cytophage Technologies Ltd CPTCF
18 GF Score
Price $0.21
! 1 Warning Sign
View Full Analysis

What is Cytophage Technologies Net Debt Paydown Yield %?

Cytophage Technologies CPTCF 18 Net Debt Paydown Yield % is 62.81% as of Jul. 05, 2026. GuruFocus rates CPTCF with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 1,163 Biotechnology companies, Cytophage Technologies ranks better than 98.02% on this metric.

Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt. As of today, Cytophage Technologies's Net Debt Paydown Yield % was 62.81%.


Cytophage Technologies  (OTCPK:CPTCF) Net Debt Paydown Yield % Explanation

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.

In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.

We calculating the TTM average debt by adding up the total debt, calculated by the sum of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation, in the trailing twelve months(TTM) divided by the counts of the total debt, accoring to the company's report frequency.


Cytophage Technologies Net Debt Paydown Yield % Related Terms


Cytophage Technologies Net Debt Paydown Yield % Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Net Debt Paydown Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Net Debt Paydown Yield % Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Debt Paydown Yield %
0.00 0.00 0.00 -4.40 2.09

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Net Debt Paydown Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.40 -5.03 -2.05 1.45 2.09

CPTCF vs VRTX, REGN, ALNY: Net Debt Paydown Yield % Comparison

For the Biotechnology subindustry, Cytophage Technologies's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytophage Technologies Net Debt Paydown Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytophage Technologies's Net Debt Paydown Yield % distribution charts can be found below:

* The bar in red indicates where Cytophage Technologies's Net Debt Paydown Yield % falls into.


CPTCF
18GF Score
Cytophage Technologies Ltd CPTCF
Net Debt Paydown Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cytophage Technologies Net Debt Paydown Yield % Calculation

Cytophage Technologies's Net Debt Paydown Yield % for the quarter that ended in Dec. 2025 is calculated as:

Net Debt Paydown Yield %
=( TTM Average Debt   (1-Year Ago))-TTM Average Debt )/Market Cap
=( 1.18-1.01 )/13.997258
=1.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

What does a Net Debt Paydown Yield % of 62.81% mean?
Cytophage Technologies (CPTCF) has a Net Debt Paydown Yield % of 62.81% as of Jul. 05, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Cytophage Technologies and its competitors. According to the industry distribution chart, Cytophage Technologies ranks #23 out of 1163 companies in the Biotechnology industry, placing it in the top 2%.
Is Cytophage Technologies' Net Debt Paydown Yield % too high?
Cytophage Technologies' current Net Debt Paydown Yield % is 62.81%. The Biotechnology industry median Net Debt Paydown Yield % is 0.03. Cytophage Technologies' value of 62.81% is 209266.7% above this industry median. Based on the distribution chart, Cytophage Technologies ranks #23 out of 1163 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Cytophage Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Cytophage Technologies' Net Debt Paydown Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cytophage Technologies ranks #23 out of 1163 companies for Net Debt Paydown Yield %. This places Cytophage Technologies in the top 2% of its industry — outperforming the majority of peers. The industry median Net Debt Paydown Yield % is 0.03. Cytophage Technologies' value of 62.81% is 209266.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Biotechnology company?
The median Net Debt Paydown Yield % among Biotechnology companies is 0.03, based on 1,163 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cytophage Technologies's current Net Debt Paydown Yield % of 62.81% is 209266.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Cytophage Technologies and its competitors. For the Biotechnology industry, the median Net Debt Paydown Yield % is 0.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cytophage Technologies's current Net Debt Paydown Yield % is 62.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (CPTCF) has a current Net Debt Paydown Yield % of 62.81%. The current Net Debt Paydown Yield % is 62.81% and 209266.7% above the Biotechnology industry median of 0.03. Cytophage Technologies' overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Cytophage Technologies (CPTCF), the current Net Debt Paydown Yield % is 62.81% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Other Exchanges CYTO.H:Canada
Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.
18GF Score

Get the complete analysis for CPTCF

Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price